Publications en collaboration avec des chercheurs de Universitat Autònoma de Barcelona (27)

2024

  1. Textbook outcome in patients with biliary duct injury during cholecystectomy

    Journal of Gastrointestinal Surgery, Vol. 28, Núm. 5, pp. 725-730

2023

  1. Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry

    The American journal of gastroenterology, Vol. 118, Núm. 10, pp. 1797-1806

  2. Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?

    Colorectal Disease, Vol. 25, Núm. 4, pp. 647-659

2022

  1. Machine Learning-Based Analysis in the Management of Iatrogenic Bile Duct Injury During Cholecystectomy: a Nationwide Multicenter Study

    Journal of Gastrointestinal Surgery, Vol. 26, Núm. 8, pp. 1713-1723

2020

  1. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: The SUNRISE study

    European Journal of Surgical Oncology, Vol. 46, Núm. 12, pp. 2195-2201

  2. Axillary staging based on molecular analysis: Results of the B-CLOSER-II study

    Pathology Research and Practice, Vol. 216, Núm. 11

  3. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals

    Frontiers in Oncology, Vol. 10

  4. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2018

  1. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

    EMBO Molecular Medicine, Vol. 10, Núm. 12

  2. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial): A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment

    Annals of Surgical Oncology, Vol. 25, Núm. 3, pp. 784-791

  3. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

    International Journal of Colorectal Disease, Vol. 33, Núm. 2, pp. 241-249

  4. P95HER2–T cell bispecific antibody for breast cancer treatment

    Science Translational Medicine, Vol. 10, Núm. 461

  5. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

    Annals of Oncology, Vol. 29, Núm. 5, pp. 1203-1210

2017

  1. Role of total tumour load of sentinel lymph node on survival in early breast cancer patients

    Breast, Vol. 33, pp. 8-13

2016

  1. Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts

    Oncotarget, Vol. 7, Núm. 42, pp. 67956-67965

2015

  1. Effect of cellular senescence on the growth of HER2-positive breast cancers

    Journal of the National Cancer Institute, Vol. 107, Núm. 5

  2. Patterns of HER2 gene amplification and response to anti-HER2 therapies

    PLoS ONE, Vol. 10, Núm. 6

  3. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer

    European Journal of Surgical Oncology, Vol. 41, Núm. 1, pp. 46-51

2014

  1. Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery

    Breast, Vol. 23, Núm. 4, pp. 460-465

  2. Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy

    Journal of the National Cancer Institute, Vol. 106, Núm. 11